Personally I believe Dr Yacov has the most to lose here by far and he has certainly done the most work here even if it was only financially . Although I believe he has done a lot more than that and that what he is putting together is a master plan . A very complex hopefully worldwide one. As everyone says as the Dr says this is not a gadget it's a clinical grade piece of equipment hopefully pitched at a price that. He will eventually sell millions of and be rewarded for his efforts . As share holders I hope we will one day too.
Obviously we are invested in a speculative stock at present and until the figures are proven and in black and white then all we can do is wait. Until the market fully realises and accept that Yacov is the real deal.
Good luck to every one who has backed the Dr . And I wish the Doctor all the luck in the world although I don't believe he will need a lot. He has done all the real hard work already. For what it's worth that's my opinion.
- Forums
- ASX - By Stock
- GMV
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-94
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online